{"anticipatedPostingDate":"2026-10","denomUnitsSelected":"Participants","description":"DOR: time from the first documentation of objective response, until confirmed PD, or death due to any cause, whichever occurred first. PD: Increase of \\>=25% from lowest confirmed response value in any 1 or more of following: serum M-component (absolute increase must be \\>=0.5 g/dL); serum M-protein increase \\>=1 g/dL, if lowest M component was \\>=5 g/dL; urine M-protein (absolute increase must be \\>=200 mg/24 h). In participants without measurable serum and urine M-protein levels, difference between involved and uninvolved serum FLC levels (absolute increase must be \\>10 mg/dL). In participants without measurable serum, urine M-protein levels and involved serum FLC levels, BM plasma-cell % irrespective of baseline status (must be \\>=10%). Appearance of a new lesion, \\>=50% increase from nadir in SPD of \\>1 lesion, or \\>=50% increase in longest diameter of a previous lesion \\>1 cm in short axis. \\>=50% increase in circulating plasma cells (minimum of 200 cells per mcL) if only measure of disease.","reportingStatus":"NOT_POSTED","timeFrame":"Parts 1 and 2: From start of treatment to end of the study (approximately 3 years 7 months)","title":"Duration of Response (DOR) Per IMWG Response Criteria as Determined by Investigator: Parts 1 and 2","type":"SECONDARY"}